Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€127.05

€127.05

2.670%
-
2.670%
-

-

 

Vifor Pharma AG Stock

There is an upward development for Vifor Pharma AG compared to yesterday, with an increase of €0.000 (2.670%).


Pros and Cons of Vifor Pharma AG in the next few years

Pros
?
Shareholder structure
?
Conscious of the environment
?
Worthwhile Investment for the next years
Cons
?
Market Position
?
Brand
?
Growth compared to competition
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Vifor Pharma AG vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Vifor Pharma AG 2.670% - - - - - -
Almirall S.A. 1.210% 6.667% 3.822% -6.034% 5.036% - -
Swedish Orphan Biovitrum Ab 0.320% -0.108% -15.841% -7.114% -15.222% 0.181% -
Dr. Reddy's Laboratories Ltd. ADR 0.990% 2.410% -6.422% 37.097% -9.735% 90.512% 17.552%

Other discussions about Vifor Pharma AG Stock

New thread Forum

News

Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1 : https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1


Regulatory News:



Vifor Pharma Group reported stable net sales and a continued strong increase in profitability in 2020, despite challenges to patient access from COVID-19 and the impact of a much

Vifor Pharma to propose Dr Alexandre LeBeaut as Board member: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma to propose Dr Alexandre LeBeaut as Board member


Regulatory News:



Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021.



Jacques